Corporate Finance

Formerly Hoth Therapeutics, Rocket One is betting its future on novel spintronic computing. A look at the tech, the risks, and the ambitious strategy.

A surge in Canadian professionals planning job changes in late 2026 reveals a market driven by new ambitions and complicated by the dual impact of AI.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

With a new sales head from Citi, OTC Markets is betting on deep industry ties to accelerate its expansion into new platforms and 24-hour trading.

Beyond a steady distribution, Chartwell's latest update signals a bold repositioning strategy. What does it mean for investors and the market?

Tiziana Life Sciences’ chairman just increased his massive stake. We analyze if this is a vote of confidence in its novel MS drug or a risky bet on a fragile biotech.

As BOXABL eyes a UK entry amid a housing crisis, is its modular tech a real solution or a strategic move to boost its upcoming public listing?

Trading Technologies partners with ICE to launch a new fixed income EMS, aiming to shatter market silos with a unified multi-asset trading experience.

Padel is exploding across North America, but its growth depends on quality infrastructure. A new partnership marries local manufacturing with global tech.

A green finance firm is investing in gas-powered data centers. Stephen Miller analyzes the $15M deal that reveals the pragmatic, and controversial, future of AI.

Venu Holding Corp. is betting big on sale-leasebacks to fund its rapid expansion, but a look at its financials reveals a high-stakes balancing act.

A bitter proxy fight erupts at Fermi Inc., pitting its founder against the board. At stake is not just the company, but its ambitious AI power grid project.

The graduation of Hemlo Mining to the TSX is more than a financial footnote. It's a story of strategic revitalization for a legendary Canadian gold camp.

China's Atom Therapeutics is advancing a dual-threat pipeline, with novel drugs for gout and a groundbreaking anti-inflammatory aimed at cardiovascular disease.

With the 2026 World Cup looming, Men in Blazers partners with NFQ Technologies to build a central digital hub, aiming to turn fleeting attention into lasting loyalty.

Syngenta joins India's ambitious Annam.AI, promising a digital future for farmers. But is this a benevolent tech leap or a strategic data grab?

Beneath resilient spending figures lies a seismic shift. Consumers are trading volume for value, forcing brands to rethink survival in an age of intention.

Orange is overhauling its debt with new hybrid notes. The move is more than financial housekeeping—it’s a strategic play to fund its global ambitions.

With exploration complete, new state laws in place, and a fortified land position, Pulsar Helium is fast-tracking its Topaz project to production.

Susan Solomon’s Tang Prize is more than an award; it's a tale of how science can save us, and a stark reminder of the irreversible challenges ahead.